Our Services
Medical Information
Helpful Resources
Published on: 5/21/2026
Doctors measure C3 and C4 levels in severe or chronic hives to detect complement activation, which can point to immune-complex mediated urticaria, urticarial vasculitis, or autoimmune disease.
Abnormal levels narrow the diagnostic pathway, guide further tests and specialist referrals, and help tailor treatment, while normal levels usually indicate non-complement causes. There are several factors to consider – see below for important details and next steps.
When someone develops hives (urticaria), it usually looks and feels like an allergic reaction. In many cases, hives clear up on their own or with simple antihistamines. However, if hives are severe, persistent, or accompanied by other signs—such as joint pain, fever, or swelling in deeper layers of the skin—doctors may order blood tests to check complement proteins C3 and C4. These tests help uncover whether the immune system's complement pathways are involved. Below, we explore why C3 and C4 complement levels are important, what they reveal, and what to do with the results.
• The complement system is a group of more than 30 proteins in your blood. It "complements" (supports) other parts of your immune system.
• C3 and C4 are two key proteins in this cascade. They circulate in an inactive form and become activated when your body senses infection or tissue injury.
• Once activated, they help:
Hives are itchy, raised welts on the skin caused by fluid leaking from small blood vessels. Most hives result from histamine release by mast cells and basophils. But in some situations, immune complexes or complement activation play a central role:
• Immune-complex–mediated urticaria
– Antibodies bind to antigens forming complexes
– These complexes activate complement, leading to inflammation and hives
• Urticarial vasculitis
– A small-vessel inflammation in which complement proteins are consumed at the site of injury
– Often presents as painful, burning hives that last more than 24 hours and may leave bruises
• Autoimmune or connective-tissue diseases
– Conditions such as systemic lupus erythematosus (SLE) can trigger hives through autoantibodies and complement activation
– Low complement levels may indicate active disease
When hives are chronic (lasting more than six weeks), unusual in appearance, or associated with systemic symptoms, doctors check complement levels to:
Detect Complement Consumption
Identify Underlying Diseases
Guide Further Testing and Treatment
| Result Pattern | What It May Indicate |
|---|---|
| Low C4, normal C3 | Classical pathway activation (e.g., early SLE) |
| Low C3 and low C4 | Active consumption in vasculitis or immune complexes |
| Normal C3 and C4 | Likely non-complement causes of hives |
| High C3 or C4 (rare) | Acute phase reaction (inflammation) |
Abnormal complement levels don't give a final diagnosis. Instead, they:
• Narrow the list of possible causes
• Prompt additional tests (e.g., ANA for lupus, cryoglobulin levels)
• Guide whether to consult a rheumatologist or immunologist
When complement activation plays a role, management may differ from standard antihistamine therapy:
• Antihistamines
• Anti-inflammatory or Immunosuppressive Treatment
• Specialist Referral
• Monitor and Adjust
Most hives are harmless and resolve quickly. However, you should talk to your doctor if you have:
If you're experiencing unusual symptoms and want to better understand what might be causing them, Ubie's free Medically approved AI Symptom Checker can help you identify potential conditions and guide your next steps in seeking care.
Remember, online tools are not a substitute for professional medical advice. If you suspect a serious or life-threatening condition, always speak to a doctor.
If you're experiencing worrisome symptoms or have questions about your lab results, please speak to a doctor. Your health depends on professional evaluation and personalized care.
(References)
* Kolkhir P, et al. Autoimmune Urticaria: Pathogenesis, Diagnosis and Treatment. Front Immunol. 2021 May 20;12:650742. doi: 10.3389/fimmu.2021.650742. PMID: 34093414; PMCID: PMC8172935.
* Zuberbier T, et al. Urticaria and Angioedema: A Practical Approach. Am J Clin Dermatol. 2022 May;23(3):367-380. doi: 10.1007/s40257-022-00681-4. Epub 2022 Feb 7. PMID: 35133642; PMCID: PMC9028059.
* Mlynek A, et al. The diagnostic value of complement factor 3 and 4 in chronic spontaneous urticaria. J Dtsch Dermatol Ges. 2020 Apr;18(4):325-331. doi: 10.1111/ddg.14088. PMID: 32281140.
* Zielen S, et al. Complement system activation in patients with chronic spontaneous urticaria. Postepy Dermatol Alergol. 2018 Dec;35(6):592-597. doi: 10.5114/ada.2018.79044. Epub 2018 Oct 31. PMID: 30745873; PMCID: PMC6360408.
* Zanichelli A, et al. Hereditary and acquired angioedema: a systematic review. Expert Rev Clin Immunol. 2021 Jan;17(1):15-28. doi: 10.1080/1744666X.2021.1856722. Epub 2020 Dec 14. PMID: 33317377.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.